Scholar Rock sets $11,659 list price for SMA drug vial
Scholar Rock (SRRK) set a $11,659 list price per single-use vial for its newly approved spinal muscular atrophy drug, described as the first therapy targeting muscle loss in SMA. The company also said the net annual cost for a typical patient will be $310,000.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.